简体中文 | 繁體中文 | English

Conference Calls

2021-07-26 09:34 IDEMIA Will Present Its H1 2021 Financial Results to Investors on July 27, 2021
2021-07-16 13:56 Bank of America Reports Second-Quarter 2021 Financial Results
2021-06-28 15:37 Schlumberger Announces Second-Quarter 2021 Results Conference Call
2021-06-24 13:13 Vifor Pharma to revise DIAMOND study, readout expected in H2 2021
2021-06-22 15:22 American Express Plans Live Audio Webcast of Second Quarter 2021 Earnings Conference Call
2021-06-03 10:19 Benson Hill – Sustainable Food Technology Company Driving the Plant-Based Food Revolution – to Combine With Star Peak Corp II
2021-05-14 13:16 Rimini Street Announces Fiscal First Quarter 2021 Financial Results
2021-05-10 19:16 Zynga Announces First Quarter 2021 Financial Results
2021-04-30 09:24 Schlumberger Announces First-Quarter 2021 Results
2021-04-28 15:20 IDEMIA Will Present Its Q1 2021 Financial Results to Investors on April 28, 2021
2021-04-22 09:59 Sale of 60.5% of ENGIE EPS by ENGIE to TCC: ENGIE EPS to Become NHOA
2021-04-22 09:46 Global Leaders of Nationwide Public Warning Systems Join Everbridge COVID-19: Road to Recovery (R2R) Executive Summit to Discuss the Future of Population Alerting
2021-04-16 14:53 Bank of America Reports First-Quarter 2021 Financial Results
2021-04-02 15:50 Takeda Hosts Wave 1 Pipeline Market Call
2021-03-18 14:12 Schlumberger Announces First-Quarter 2021 Results Conference Call
2021-03-16 09:45 Bentley Systems Enters into ~ $1.05 Billion Agreement to Acquire Seequent, Global Leader in 3D Modeling Software for the Geosciences
2021-03-10 14:12 DeepGreen, Developer of the World's Largest Estimated Resource of Battery Metals for EVs, to Combine with Sustainable Opportunities Acquisition Corporation
2021-03-09 12:14 Rimini Street Announces Fiscal Fourth Quarter and Annual 2020 Financial Results
2021-03-08 10:03 Takeda Secures Global Rights from Ovid Therapeutics to Develop and Commercialize Soticlestat for the Treatment of Children and Adults with Dravet Syndrome and Lennox-Gastaut Syndrome
2021-03-03 14:20 Vifor Pharma delivers strong full year results 2020 with an EBITDA of 576 million Swiss Francs representing over 29% growth1

Business Wire Weibo

Press Releases

Latest Releases